Screening for Pancreatic Adenocarcinoma in BRCA2 Mutation Carriers: Results of a Disease Simulation Model
Pari V. Pandharipande(Massachusetts General Hospital), Chin Hur(Columbia University Irving Medical Center), William R. Brugge(Massachusetts General Hospital), Curtis R. Heberle(Massachusetts General Hospital), Daniel C. Chung(Massachusetts General Hospital), Emily C. Dowling(Massachusetts General Hospital), Alvin Jeon(Center for Assessment), Chung Yin Kong(Center for Assessment)
Cited by 15
Related Papers
Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune Microenvironment
|Cell Host & Microbe|2013|2.7k
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer
|Nature Medicine|2004|2k
Gastroenteropancreatic neuroendocrine tumours
|The Lancet Oncology|2008|1.8k
Celecoxib for the Prevention of Sporadic Colorectal Adenomas
|New England Journal of Medicine|2006|1k
The Chromosomal Instability Pathway in Colon Cancer
|Gastroenterology|2010|932